Related Experiment Video

Updated: May 8, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Lipid lowering therapy in geriatric patients]

M Lechleitner1

  • 1Landeskrankenhaus Hochzirl, Anna-Dengel-Haus, 6170 Zirl, Österreich. Monika.lechleitner@tilak.at

Zeitschrift Fur Gerontologie Und Geriatrie
|August 20, 2013
PubMed

Insights

Cardiovascular disease is a leading cause of death in older adults. Lipid-lowering therapy with statins is important but requires careful consideration of individual risk profiles and potential side effects in the elderly.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Context:

  • Cardiovascular disease is the primary cause of mortality in the elderly.
  • Older adults increasingly undergo invasive procedures to maintain quality of life.
  • Preventive strategies, like lipid-lowering therapy, are crucial for this demographic.

Purpose:

  • To evaluate the importance of lipid-lowering therapy in the elderly.
  • To discuss the benefits and risks of statin therapy in older patients.
  • To emphasize individualized treatment decisions based on risk profiles.

Summary:

  • Statin therapy is vital for preventing cardiovascular events in the elderly.
  • Potential side effects include drug interactions, myopathy, and possible impacts on cognitive function.
  • Some studies suggest a link between statins and an increased risk of type 2 diabetes in specific groups.

Impact:

  • Highlights the need for personalized risk-benefit assessments for statin use in older individuals.
  • Informs clinical practice regarding the cautious application of lipid-lowering therapies in geriatric populations.
  • Underscores the importance of ongoing research into statin's long-term effects in the elderly.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...